Table:
| Period | Total number of Shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced plans or programs | Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs |
| --- | --- | --- | --- | --- |
| October 1 to October 31 | 3,646,581 (i) | 97.28 (ii) | — | — |
| November 1 to November 30 | 1,096,773 (iii) | — (ii) | — | — |
| December 1 to December 31 | — | — | — | — |
| Total | 4,743,354 | 97.28 (ii) | — | — |
Paragraphs:
Issuer Purchases of Equity Securities
(i) Includes 3,416 shares that have been withheld by the Company to satisfy its tax withholding and remittance obligations in connection with the vesting of restricted stock awards. In addition, the Company exercised a pro-rata portion of the 2022 convertible note hedges (described in Note 12, Indebtedness, of the Notes to the Consolidated Financial Statements) to offset the shares of the Company’s Class A common stock issued to settle the conversion of certain 2022 Notes. The note hedges were net share settled and the Company received 3,643,165 shares of the Company’s Class A common stock from the counterparties in October of 2018.
(ii) Excludes the shares received through the exercise of the note hedges.
(iii) The Company exercised a pro-rata portion of the 2022 convertible note hedges to offset the shares of the Company’s Class A common stock issued to settle the conversion of certain 2022 Notes. The note hedges were net share settled and the Company received 1,096,773 shares of the Company’s Class A common stock from the counterparties in November of 2018.
Question:
What are the months provided in the period column?
Answer: October, November, December